NTCOC
WINT

Northern Trust Company of Connecticut’s Windtree Therapeutics Inc WINT Stock Holding History

Northern Trust Company of Connecticut’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$35K Hold
1,106
– – ﹤0.01% 1964
2013
Q3 		$30K Hold
1,106
– – ﹤0.01% 1952
2013
Q2 		$24K Buy
+1,106
New +$27.2K ﹤0.01% 1934

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Company of Connecticut's WINT Position: Q4 2013 in Review

Northern Trust Company of Connecticut held its Windtree Therapeutics Inc (WINT) position steady in Q4 2013 at 1,106 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #1964.

Northern Trust Company of Connecticut first reported a position in WINT in Q2 2013 and has held it in 3 quarters since. 60 funds tracked by Wall St. Rank hold WINT as of Q4 2013.

  • Northern Trust Company of Connecticut held 1,106 shares of Windtree Therapeutics Inc worth $35K as of Q4 2013.
  • Northern Trust Company of Connecticut left its Windtree Therapeutics Inc share count unchanged in Q4 2013.
  • Windtree Therapeutics Inc made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1964 holding.
  • Northern Trust Company of Connecticut first reported a position in Windtree Therapeutics Inc in Q2 2013 and has held it in 3 quarters since.
  • 60 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.